跳至主要内容
临床试验/NCT00913523
NCT00913523已完成不适用

Vaginal Lactobacillus and Other Key Microflora During and After Menses in Women Using Tampons Containing Glycerol Monolaurate (GML) and Women Using Tampons Without GML

Johnson & Johnson Consumer and Personal Products Worldwide3 个研究点 分布在 1 个国家目标入组 482 人开始时间: 2009年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
482
试验地点
3
主要终点
Percentage of Subjects Showing Unfavorable Changes in Primary Microflora

研究概览

简要总结

Subjects will be using investigational or control tampons during their menstrual period but these tampons are not intended to prevent, treat or diagnose an infection or other disease condition. A total 450 women will participate in this study at two study sites. Subjects will be randomly assigned to one of three tampon groups. The first group will test an experimental test tampon containing glycerol monolaurate (GML) on the cover. The second group will test an identical tampon, but without GML. The third group will not be issued study tampons but will be instructed to use their normal tampon brand. This study is intended to determine whether the effects of GML observed in the laboratory can be demonstrated in healthy menstruating women.

详细描述

Subjects will be using investigational or control tampons during their menstrual period but these tampons are not intended to prevent, treat or diagnose an infection or other disease condition. This study will be a randomized, single-blinded, multi-center study of women using Tampons with GML, Tampons without GML or the Tampons Normally Used for one menstrual period. Subjects will undergo Baseline microflora evaluations taken from the vaginal walls 5-10 days following their menstrual period (Baseline evaluation). Subjects will be randomly assigned to use one of the three study products during their next menstrual period. Microflora will be re-evaluated in samples taken from the tampons and from the vaginal walls during use of the study tampons, and from vaginal walls soon after the end of the menstrual period. Evaluations of microflora will be done by quantitative cultures of tampons and vaginal swabs, and also by Nugent scoring of the vaginal swabs. Staphylococcal α-hemolysin and TSST-1 will be analyzed in extracts of the study tampons from subjects found to be colonized with S. aureus. Vaginal pH will be measured, using electronic meters, at each clinic visit. All samples (tampons and vaginal swabs) will be analyzed at a central microbiology laboratory. Extracts of tampons found to contain S. aureus will be forwarded to another central laboratory for the toxin assays. Personnel in the central laboratories will be blinded to the group assignment (study product) for each subject until completion of the study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • normal healthy women
  • 18-45 years of age
  • regular 21- to 35-day menstrual cycles with at least 5 days of bleeding, or at least 3 days of bleeding if they are using hormonal contraception
  • used tampons as their principal mode of menstrual sanitary protection for at least the previous 6 months
  • willing to not change their feminine care or hygiene practices during their participation in the study (except as directed by the protocol and instructions for participants)

排除标准

  • signs or symptoms of clinically significant vulvovaginal infection or vaginosis
  • history of recurrent urinary tract or vulvovaginal infection
  • abnormal vaginal discharge of any etiology
  • use of a systemic, vaginal, or perineal antibiotic, antifungal, anti-infective, or immunosuppressant medication or any experimental drug or medical device within the 30 days preceding the Screening/Baseline Visit
  • history of treatment for Toxic Shock Syndrome (TSS) or a suspicion of having had TSS
  • other clinical issues or history (per protocol) that would make participation in the trial inappropriate

结局指标

主要结局

Percentage of Subjects Showing Unfavorable Changes in Primary Microflora

时间窗: Mid-Cycle Baseline to Mid-Menstrual Samples

Percentage of subjects showing unfavorable changes of at least 1-log in lactobacilli (decrease), C. albicans (increase), or G. vaginalis (increase)

次要结局

  • Percentage of Subjects Showing Unfavorable Changes in Primary Microflora(Mid-Cycle Baseline to Post-Menstrual Samples)
  • Percentage of Subjects With Selected Microflora in Tampons(During Menses)
  • Abundance of Selected Microflora in Tampons(During Menses)
  • Changes in Nugent Score(Mid-Cycle Baseline to Post-Menstrual Samples)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验